Researchers at the University of Pennsylvania announced breakthrough early research news in treating advanced chronic lymphocytic leukemia (CLL) patients with genetically engineered versions of their own T cells. Following a flurry of articles about gene therapy and leukemia, how can you determine what this news could mean for you? In this podcast, we are joined by Dr. David Porter--the study's co-principal investigator--as he explains the details of the pilot trial and its possible impact on people living with leukemia.Source: Patient Power | Aired: September 18, 2011
